Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
PEHO-like syndrome is a rare, genetic neurological disease characterized by progressive encephalopathy, early-onset seizures with a hypsarrhythmic pattern, facial and limb edema, severe hypotonia, early arrest of psychomotor development and craniofacial dysmorphism (evolving microcephaly, narrow forehead, short nose, prominent auricles, open mouth, micrognathia), in the absence of neuro-ophthalmic or neuroradiologic findings. Poor visual responsiveness, growth failure and tapering fingers are also associated.
Features include always present findings: Narrow forehead, Epicanthus, Bilateral tonic-clonic seizure, and Hypsarrhythmia and others. 30 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 9 | Bilateral tonic-clonic seizure, Profound intellectual disability, Enlarged brain ventricles (ventriculomegaly) |
CCDC88A encodes coiled-coil and HOOK domain protein 88A (1,871 aa). Bifunctional modulator of guanine nucleotide-binding proteins (G proteins). Highest expression in Testis (34.2 TPM) and Brain Spinal cord cervical c-1 (28.7 TPM).
PEHO-like syndrome is associated with mutations in the CCDC88A gene on chromosome 2.
CCDC88A is classified as a druggable target (Kinase category) with score 0.0.
Genetic testing for CCDC88A is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 28 always present features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for PEHO-like syndrome.
4 publications have been identified in PubMed for PEHO-like syndrome. Research spans Basic Science / Preclinical (75%) and Case Report / Case Series (25%).
Chen F (2026). [PMID: 41857137](https://pubmed.ncbi.nlm.nih.gov/41857137/). *Cell death and differentiation*. [Basic Science / Preclinical]
Lehtonen J (2025). [PMID: 40401444](https://pubmed.ncbi.nlm.nih.gov/40401444/). *Human molecular genetics*. [Basic Science / Preclinical]
Papuc SM (2024). [PMID: 39334473](https://pubmed.ncbi.nlm.nih.gov/39334473/). *Italian journal of pediatrics*. [Case Report / Case Series]
Rahman ML (2024). [PMID: 39252897](https://pubmed.ncbi.nlm.nih.gov/39252897/). *medRxiv : the preprint server for health sciences*. [Basic Science / Preclinical]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 12:19 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about PEHO-like syndrome
Muscles
4 |
Shrinkage of the cerebellum (cerebellar atrophy), Low muscle tone (hypotonia), Damage to the optic nerve (optic atrophy) |
Head and neck | 1 | Progressive microcephaly |
Digestive system | 1 | Feeding difficulties |
Arms and legs | 1 | Tapered finger |
Eyes | 1 | Damage to the optic nerve (optic atrophy) |
Pregnancy and birth | 1 | Neonatal hypotonia |
Age of onset: childhood.